Clinical Trial Update: Clinical Assessment of Spinal Muscular Atrophy Type II and III (SMA Europe) [NA]

View source ↗

Summary

The SMA Europe-sponsored clinical assessment of Spinal Muscular Atrophy Type II and III, sponsored by Institut de Myologie in France, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Muscular Atrophy

Snippet

Sponsor: Institut de Myologie, France | Conditions: Spinal Muscular Atrophy | NA | Status: COMPLETED